Omega Fund IV GP, L.P.'s Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:35PM EST
Who is Omega Fund IV GP, L.P.?
Omega Fund IV GP, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., Replimune Group, Inc., Translate Bio, Inc., Paratek Pharmaceuticals, Inc., and Nuvation Bio Inc..
SEC CIK
Omega Fund IV GP, L.P.'s CIK is 0001528383
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.58
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.39M |
—
|
—
| 1.39M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.94% | -90.00K |
$12.64 | -$1,495,112.88 | 9.44M |
Mar 14 - Mar 16
| |||
Form 4
| -0.94% | -45.42K |
$34.58 | -$1,570,679.30 | 4.76M |
Scheduled
|
Nov 19 - Nov 22
| ||
Form 4
| -0.05% | -2.59K |
$33.50 | -$86,899.00 | 4.81M |
Scheduled
|
Nov 16 - Nov 18
| ||
Form 4
| -0.05% | -2.59K |
$33.50 | -$86,899.00 | 4.81M |
Scheduled
|
Nov 16 - Nov 18
| ||
Form 4
| -0.50% | -24.02K |
$33.66 | -$808,412.22 | 4.81M |
Scheduled
|
Nov 12 - Nov 15
| ||
Form 4
| -0.38% | -18.29K |
$33.61 | -$614,725.69 | 4.84M |
Scheduled
|
Nov 10 - Nov 11
| ||
Form 4
| -0.23% | -11.35K |
$33.66 | -$382,207.02 | 4.85M |
Scheduled
|
Nov 8 - Nov 9
| ||
Form 4
| -0.63% | -31.02K |
$33.57 | -$1,041,020.50 | 4.87M |
Scheduled
|
Nov 4 - Nov 5
| ||
Form 4
| -0.25% | -12.17K |
$33.58 | -$408,702.18 | 4.9M |
Scheduled
|
Sep 23
| ||
Form 4
| -2.00% | -100.00K |
$32.99 | -$3,299,008.74 | 4.91M |
Scheduled
|
Sep 16 - Sep 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -0.10% | -5.25K |
$45.00 | -$236,205.00 | 5.14M |
Scheduled
|
Feb 8
| ||
Form 4
| -0.57% | -30.35K |
$45.42 | -$1,378,444.10 | 5.28M |
Scheduled
|
Jan 26
| ||
Form 4
| -0.21% | -11.36K |
$45.04 | -$511,657.57 | 5.31M |
Scheduled
|
Jan 22
| ||
Form 4
| -0.37% | -19.58K |
$45.10 | -$883,053.80 | 5.33M |
Scheduled
|
Jan 14 - Jan 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +4.31% | 220K |
$13.61 | $2,994,200.00 | 5.33M |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 4.85M |
$15.00 | $4,000,005.00 | 4.85M |
Jul 19 - Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Translate Bio, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.88M |
—
|
—
| 4.88M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Paratek Pharmaceuticals, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nuvation Bio Inc. (NUVB) Snapshot price: $2.85
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.13% | -500.00K |
$10.07 | -$5,035,000.00 | 22.96M |
Dec 15
| |||
| No matching records found | |||||||||